Peptides derived of kunitz-type serine protease inhibitor as potential vaccine against experimental schistosomiasis
J. Hernandez-Goenaga, J. Lopez-Aban, A. V. Protasio, B. Vicente, E. del Olmo, M. Vanegas, P. Fernandez-Soto, M. A. Patarroyo, A. Muro
This study evaluates the protective efficacy of peptides derived from a kunitz-type serine protease inhibitor in a vaccine against schistosomiasis, showing significant reductions in parasite recovery and organ damage in vaccinated mice.
bioRxiv · May 10, 2019Immunology